Tom Riesenberg has joined GE Healthcare Information Technologies (Waukesha, Wisconsin) as global general manager of the company’s Imaging business. Riesenberg will oversee GE’s technologies that enable radiologists to manage the storage and sharing of medical images acquired from imaging systems, including computed tomography, magnetic resonance and X-ray. He will be based in GE’s Mount Prospect, Illinois, offices. Risenberg has nearly 30 years of experience in healthcare IT and joins GE from Siemens Medical Solutions, where he most recently worked in the company’s corporate offices in Erlangen, Germany, as director of global implementations for the Image Management business. He came to Siemens through its acquisition of Shared Medical Systems after working for that firm for 18 years.

• Molecular Insight Pharmaceuticals (Cambridge, Massachusetts) has appointed John Barrett, PhD, as vice president of research and promoted James Kronauge, PhD, to vice president of process chemistry. Barrett has more than 20 years of R&D experience in cardiology, imaging and oncology with various companies, most recently with Infinity Pharmaceuticals. Kronauge, a member of Molecular Insight’s research team since 1999, most recently was director of pre-clinical development. The company’s development pipeline includes BMIPP (iodofiltic acid I123), a molecular imaging pharmaceutical for the detection of cardiac ischemia, and Ultratrace MIBG (MIP-120T) for the treatment of neuroendocrine tumors.

Ian Currie has been appointed European sales manager of Nonlinear Dynamics Ltd. (Newcastle Upon Tyne, UK), a provider of bioinformatics solutions. He previously was with Amersham Biosciences, now part of GE Health-care, serving as project manager for the development of a software product. Nonlinear Dynamics’ product portfolio includes analysis and datamining tools for 1-D and 2-D electrophoresis gels and microarrays, the core technologies of genomics and proteomics.

No Comments